| Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses P Chen, W Hübner, MA Spinelli, BK Chen Journal of virology 81 (22), 12582-12595, 2007 | 502 | 2007 |
| Common tasks in microscopic and ultrastructural image analysis using ImageJ F Papadopulos, M Spinelli, S Valente, L Foroni, C Orrico, F Alviano, ... Ultrastructural pathology 31 (6), 401-407, 2007 | 272 | 2007 |
| The interplay between HIV and COVID-19: summary of the data and responses to date LB Brown, MA Spinelli, M Gandhi Current Opinion in HIV and AIDS 16 (1), 63-73, 2021 | 173 | 2021 |
| Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms MJ Peluso, AN Deitchman, L Torres, NS Iyer, SE Munter, CC Nixon, ... Cell Reports 36 (6), 2021 | 154 | 2021 |
| SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ... Science advances 7 (31), eabh3409, 2021 | 130 | 2021 |
| SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study MA Spinelli, KL Lynch, C Yun, DV Glidden, MJ Peluso, TJ Henrich, ... The lancet HIV 8 (6), e334-e341, 2021 | 114 | 2021 |
| Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions MA Spinelli, JE Haberer, PR Chai, J Castillo-Mancilla, PL Anderson, ... Current Hiv/Aids Reports 17, 301-314, 2020 | 100 | 2020 |
| Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19 MA Spinelli, MD Hickey, DV Glidden, JQ Nguyen, JJ Oskarsson, D Havlir, ... Aids 34 (15), 2328-2331, 2020 | 92 | 2020 |
| Chronic viral coinfections differentially affect the likelihood of developing long COVID MJ Peluso, TM Deveau, SE Munter, D Ryder, A Buck, G Beck-Engeser, ... The Journal of clinical investigation 133 (3), 2023 | 82 | 2023 |
| Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity MA Spinelli, DV Glidden, ED Gennatas, M Bielecki, C Beyrer, ... The Lancet Infectious Diseases 21 (9), e296-e301, 2021 | 69 | 2021 |
| Factors associated with substance use in older homeless adults: Results from the HOPE HOME study MA Spinelli, C Ponath, L Tieu, EE Hurstak, D Guzman, M Kushel Substance abuse 38 (1), 88-94, 2017 | 67 | 2017 |
| Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement MJ Peluso, JD Kelly, S Lu, SA Goldberg, MC Davidson, S Mathur, ... Open forum infectious diseases 9 (2), ofab640, 2022 | 65 | 2022 |
| Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics HM Scott, M Spinelli, E Vittinghoff, A Morehead-Gee, A Hirozawa, ... Aids 33 (14), 2189-2195, 2019 | 64 | 2019 |
| Brief report: validation of a urine tenofovir immunoassay for adherence monitoring to PrEP and ART and establishing the cutoff for a point-of-care test M Gandhi, P Bacchetti, MA Spinelli, H Okochi, JM Baeten, O Siriprakaisil, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (1), 72-77, 2019 | 61 | 2019 |
| Missed visits associated with future preexposure prophylaxis (PrEP) discontinuation among PrEP users in a municipal primary care health network MA Spinelli, HM Scott, E Vittinghoff, AY Liu, R Gonzalez, A Morehead-Gee, ... Open forum infectious diseases 6 (4), ofz101, 2019 | 60 | 2019 |
| Understanding PrEP persistence: provider and patient perspectives ND Laborde, PM Kinley, M Spinelli, E Vittinghoff, R Whitacre, HM Scott, ... AIDS and Behavior 24, 2509-2519, 2020 | 56 | 2020 |
| Development and validation of an immunoassay for tenofovir in urine as a real-time metric of antiretroviral adherence M Gandhi, P Bacchetti, WC Rodrigues, M Spinelli, CA Koss, PK Drain, ... EClinicalMedicine 2, 22-28, 2018 | 53* | 2018 |
| Differences in post-mRNA vaccination severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test … MA Spinelli, MJ Peluso, KL Lynch, C Yun, DV Glidden, TJ Henrich, ... Clinical Infectious Diseases 75 (1), e916-e919, 2022 | 50* | 2022 |
| Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19 MJ Peluso, JD Kelly, S Lu, SA Goldberg, MC Davidson, S Mathur, ... MedRxiv, 2021 | 50 | 2021 |
| COVID-19 outcomes and risk factors among people living with HIV MA Spinelli, BLH Jones, M Gandhi Current HIV/AIDS Reports 19 (5), 425-432, 2022 | 49 | 2022 |
Dave GliddenProfessor of Biostatistics, UC San FranciscoVerified email at ucsf.edu
